Tampere University of Technology

TUTCRIS Research Portal

Research group: Molecular Signaling Lab

Research unit: Research Group

  1. Published

    2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma

    Viswanathan, A., Kute, D., Musa, A., Mani, S. K., Sipilä, V., Emmert-Streib, F., Zubkov, F. I., Gurbanov, A. V., Yli-Harja, O. & Kandhavelu, M., 15 Mar 2019, In : European Journal of Medicinal Chemistry. 166, p. 291 - 303

    Research output: Contribution to journalArticleScientificpeer-review

  2. Published

    Alkylaminophenol induces G1/S phase cell cycle arrest in glioblastoma cells through p53 and cyclin-dependent kinase signaling pathway

    Doan, P., Musa, A., Candeias, N. R., Emmert-Streib, F., Yli-Harja, O. & Kandhavelu, M., 2019, In : FRONTIERS IN PHARMACOLOGY. 10, APR, 330.

    Research output: Contribution to journalArticleScientificpeer-review

  3. Published

    Analysis of Ca2+ and cAMP signaling regulated by GPR17 at single cell level.

    Palanivel, S., Yli-Harja, O. & Kandhavelu, M., 5 Dec 2014, p. 88. 1 p.

    Research output: Other conference contributionPaper, poster or abstractScientific

  4. Published

    Antibacterial and antitumor properties of alkylaminophenols derived from Petasis borono-Mannich multicomponent reaction

    Rafael Candeias, N., Rijo, P. & Kandhavelu, M., 2017.

    Research output: Other conference contributionPaper, poster or abstractScientific

  5. Published

    Antimicrobial activity and molecular analysis of azoderivatives of β-diketones

    Viswanathan, A., Sala, A., Yli-Harja, O. & Kandhavelu, M., 23 Jan 2015, In : European Journal of Pharmaceutical Sciences. 66, p. 83-89 7 p.

    Research output: Contribution to journalArticleScientificpeer-review

  6. Published

    Base catalysed N-functionalisation of boroxazolidones

    J., R., Mannoja, J., Nguyen, T., N., A., N. M., K., Franzén, R. G., Kandhavelu, M. & Candeias, N. R., 2017, In : RSC Advances. 7, 33, p. 20620-20627 8 p.

    Research output: Contribution to journalArticleScientificpeer-review

  7. Published

    Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation)

    Viswanathan, A., Musa, A., Murugesan, A., Vale, J. R., Afonso, C. A. M., Konda Mani, S., Yli-Harja, O., Candeias, N. R. & Kandhavelu, M., 12 Dec 2019, In : Cells. 8, 12, 18 p., 1624.

    Research output: Contribution to journalArticleScientificpeer-review

  8. Published

    Development of efficient cell segmentation tool for microscope image

    Sandberg, O., Palanivel, S., Doan, P., Yli-Harja, O. & Kandhavelu, M., 2015.

    Research output: Other conference contributionPaper, poster or abstractScientific

  9. Published

    GPR17 is a novel target for personalized medicine for glioblastoma

    Doan, P., Musa, A., Nguyen, T., Saravanan, K. M., Sipilä, V., Emmert-Streib, F., Yli-Harja, O. & Kandhavelu, M., 2018, The 4th Annual Finnish Symposium on Brain Tumors, FIBTRA: Vanajanlinna, Hämeenlinna, 29-30 November 2018.

    Research output: Chapter in Book/Report/Conference proceedingConference contributionScientificpeer-review

  10. Published

    hGPR17 signaling cascade effects mitochondrial function

    Kandhavelu, M., 2016, In : The FEBS Journal. 283, S1

    Research output: Contribution to journalMeeting AbstractScientificpeer-review

Previous 1 2 3 Next

ID: 10548573